Henry Yen-Cheng Pan

The Royal Melbourne Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Henry Yen-Cheng Pan is a leading figure in molecular imaging and prostate cancer research, with a focused expertise on the clinical application of prostate-specific membrane antigen (PSMA). His work bridges the critical gap between radiology and pathology, demonstrating how PSMA-PET avidity on scans correlates with stronger PSMA immunohistochemistry staining on biopsy cores. This foundational contribution provides a direct, evidence-based link between non-invasive imaging and the underlying molecular biology of prostate cancer, validating PSMA as both a reliable imaging target and a histopathological marker. Though his most cited work is recent, its impact is already significant, with 2 citations in 2026 alone, signaling its rapid adoption by the field. Dr. Pan’s research is pivotal for refining patient selection for PSMA-targeted therapies and improving diagnostic accuracy. His achievements underscore a commitment to translating molecular insights into practical, patient-centered tools, making him a key voice in the evolution of precision oncology for prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Prostate‐specific membrane antigen ( <scp>PSMA)</scp> ‐ <scp>PET</scp> ‐avid prostate cancers show stronger <scp>PSMA</scp> immunohistochemistry staining on biopsy cores
2 citations · 2026
📈 Most Prolific Year: 2026 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: The Royal Melbourne Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago